BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Report Library

All Reports
Datamonitor Healthcare Respiratory Disease Analysis: Asthma

August 10, 2020

Asthma is a chronic respiratory condition characterized by recurrent wheezing, coughing, and breathlessness, which occur in acute events known as exacerbations. Often triggered by factors such as exercise, allergen or irritant exposure, change in weather, or viral respiratory infections, these flare-ups can vary significantly in frequency and severity. Attacks consist of swelling of the lining of the bronchial tubes, which narrows airways and results in a reduction of airflow into and out of the lungs. Historically considered to be a single disease, asthma is now viewed more as an overlapping assemblage of individual phenotypes with various underlying pathophysiological processes leading to symptoms.

The Global Asthma Report has estimated that asthma affects 339 million people worldwide. It is the most common noncommunicable ailment among children, and is often poorly controlled. Asthma can be difficult to define and diagnose, and some diagnostic measures are physically demanding on the patient. Currently, there is no “gold standard” in diagnosis, which makes finding a standard definition difficult. Some studies suggest that over a quarter of adults diagnosed with asthma do not have clear evidence of this condition.

This Datamonitor Healthcare report contains a Disease Analysis module.
Indications Covered: Asthma
Back to the top Back to the top